A mouse study shows cocaine takes over an existing brain circuit for mouth and face movements, locking behavior into rigid, ...

AbbVie's Juvmo (tavapadon) receives FDA approval as the first selective D1/D5 agonist for Parkinson's disease treatment.

JUVMO™ is the first and only selective D1/D5 receptor agonist approved for adults with Parkinson's disease1 Taken once daily with or without levodopa therapy, JUVMO offers patients ...

Researchers have identified a brain circuit that normally supports flexible behavior, but is recruited by cocaine to drive ...

Researchers identify a brain circuit that normally supports flexible behavior, but is recruited by cocaine to drive increasingly rigid and repetitive ...

A brain system that normally helps keep behaviour flexible may be turned against itself by cocaine, Israeli scientists have found. The discovery could help explain how compulsive and repetitive ...

Parkinson’s disease has long been described in terms of its most visible features: the tremor, the slowed movement, the ...

Researchers have identified a brain circuit that normally supports flexible behavior but is recruited by cocaine to drive ...

Among patients with out-of-hospital cardiac arrest (OHCA), direct transfer to a primary percutaneous coronary intervention (PPCI) center was associated with lower 3-year mortality than indirect ...

It’s true. Rates of Parkinson’s disease are growing faster than any other neurological condition in the world, with incidence projected to double in the coming decades. Parkinson’s is a progressive ...

People are always asking, “When is the next Nintendo Direct??” And for the next few days, the appropriate answer is, “Which one?” That’s because Nintendo is going big this September with two Nintendo ...

Parkinson’s disease music therapy is backed by peer-reviewed science: external rhythm bypasses the brain’s damaged timing circuit, improving gait velocity by 15-20%. Ahead of its TIFF premiere Sept.